Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.
about
Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1Macrophages and cytokines in the early defence against herpes simplex virusInfiltrating cells and IFNgamma production in the injected eye after uniocular anterior chamber inoculation of HSV-1.Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neuronsBioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in αßγ interferon receptor-deficient mice.The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responsesToll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infectionIdentification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.Herpes keratitis.Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin.Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of LeukocytesLethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1.Reduced degranulation of NK cells in patients with frequently recurring herpes.Interferon-gamma, macrophages, and virus spread after HSV-1 injection.Activation and evasion of innate antiviral immunity by herpes simplex virusInnate and adaptive immune responses to herpes simplex virusOligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system.Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear EnvironmentDendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and ImmunopathologyCorticosterone, inflammation, immune status and telomere length in frigatebird nestlings facing a severe herpesvirus infection.Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma.The case for immunomodulatory approaches in treating HSV encephalitis.Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1.Re-evaluating natural resistance to herpes simplex virus type 1.Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1Δγ₁134.5 herpes simplex viruses encoding human cytomegalovirus IRS1 or TRS1 induce interferon regulatory factor 3 phosphorylation and an interferon-stimulated gene response.Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.Suppression of the interferon-mediated innate immune response by pseudorabies virus.Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes.Porcine reproductive and respiratory syndrome virus nonstructural protein 4 antagonizes beta interferon expression by targeting the NF-κB essential modulator.Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
P2860
Q24814677-D4BF8DC9-491B-45EB-9068-C5EB8130179BQ24815062-2D3BD6D1-ECCA-4C59-9391-B4B0AEBC215FQ33624451-5D0BB989-30B5-402F-A428-58A5D6532614Q33900347-27B2819D-2914-4981-84A2-EA4D46B64D60Q33937809-97F39A75-8A40-41FD-8760-D6A4272315B0Q34018897-FB590395-BCA7-400F-9CEF-990A01E5A38DQ34046154-051F8001-1A1F-4300-B76A-01CAF1275647Q34254496-914A5E96-00DF-4C32-8044-A308AD34DFB5Q34294746-A807399F-5A2D-47AB-AD47-C497A631EB91Q34297293-7CF7DE1B-89B2-4DB0-A734-F38FA303F500Q34350245-65C143ED-953C-4CD7-B1FA-392A9037F813Q34545982-615077C9-BA43-4DDB-B93B-CD9B8F6AE26DQ34885415-21629556-1C8B-4C2F-B439-96744EF03F96Q34998251-6106709E-D237-4EFF-B74F-68A223B0DBD4Q35013167-6BF39396-3EF4-42FA-B631-21AB4BCD1AE7Q35058178-EC190A69-120E-423B-8E40-FA54B4DE35BCQ35087776-EC8443CC-50D7-4144-A735-5A0D093AA597Q35191244-16DEB521-33AD-46F0-BBFE-69C5C8F309C9Q35220908-868798A2-5279-42C6-B0BF-0F9E279FC711Q35259878-3E70A25A-8EF3-4DE2-AE81-4310614DB157Q35260078-67E89247-4FC0-412D-BD2B-83F4217221E0Q35783093-27599D25-8138-41F3-A4D7-458373B20F69Q35857784-E7552C0A-EAD8-4991-9E71-D6C38CE80677Q35868054-87ED3356-D70D-4A20-BE5F-E80B5365D60CQ36130131-19FABE4D-BE8B-4617-8579-4306AE64A8E4Q36227278-F1B0BE68-D361-4B54-A310-A3694E61D840Q36245115-82E5F402-25CD-4C24-9263-10E42156B4EEQ36400754-A40CE4FA-C603-470E-A6F3-5BBBE91731ADQ37091308-57A2319A-E87B-45B3-9567-65FF1CDF8DDDQ37127934-6CE9DAF9-BD24-4A38-8F50-9355FDA82C2CQ37492787-F915A08A-A929-4356-B48A-0B7012BED094Q39410081-F9960101-9B52-4CFD-972D-0BC16F7D384FQ39445325-30F2BECC-6B52-491F-A0AE-31095FEB7D8AQ39644780-81E9D7FD-46C9-4DCB-8FFD-B2557EE3AB25Q40140935-AB3648CB-C8B2-4DF4-ABBD-477D2620D3CFQ40229229-C30DEE1C-B558-4283-AEB7-E9F96537FAD9Q40267826-1B6B6369-A3F4-4E70-94D5-0D08015152BDQ40355385-65678317-B69A-444E-88BB-B9BC06D944B0Q42206807-1B5419F5-0989-4A2B-B7CF-D42C3C0E29ADQ44164534-EAD4BFE1-75FE-47FC-9E15-3D73D386E5CF
P2860
Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interplay between alpha/beta a ...... t herpes simplex virus type 1.
@en
Interplay between alpha/beta a ...... t herpes simplex virus type 1.
@nl
type
label
Interplay between alpha/beta a ...... t herpes simplex virus type 1.
@en
Interplay between alpha/beta a ...... t herpes simplex virus type 1.
@nl
prefLabel
Interplay between alpha/beta a ...... t herpes simplex virus type 1.
@en
Interplay between alpha/beta a ...... t herpes simplex virus type 1.
@nl
P2093
P2860
P1433
P1476
Interplay between alpha/beta a ...... st herpes simplex virus type 1
@en
P2093
Cornelia Schwerdel
Gottfried Alber
Marco Franchini
Mark Suter
Mathias Ackermann
Sabine Vollstedt
Susi Arnold
P2860
P304
P356
10.1128/JVI.78.8.3846-3850.2004
P407
P577
2004-04-01T00:00:00Z